태아 모니터링 시장 - 세계 산업 규모, 점유율, 동향, 기회와 예측 : 제품별, 휴대성별, 방법별, 용도별, 최종사용자별, 지역별＆경쟁(2021-2031년)

The Global Fetal Monitoring Market is projected to expand from USD 6.16 Billion in 2025 to USD 9.25 Billion by 2031, reflecting a compound annual growth rate of 7.01%. This sector focuses on the continuous evaluation of fetal vital signs, such as heart rates and uterine contractions, to safeguard health during pregnancy and labor. Growth is largely fueled by the rising incidence of preterm births and high-risk pregnancies, which demand intense surveillance to ensure safety. Furthermore, increasing maternal age globally has heightened the necessity for careful monitoring to handle complications and reduce mortality risks. For example, the March of Dimes reported that the preterm birth rate in the United States held steady at a worrying 10.4% in 2024, underscoring the ongoing need for these diagnostic tools to tackle maternal health challenges.

Despite these drivers, market progress faces significant hurdles due to the high costs involved in purchasing and maintaining medical-grade systems. This financial burden restricts the deployment of essential equipment in smaller clinics and lower-income areas, thereby limiting broader market penetration. Moreover, the need for specialized training to correctly analyze monitoring data creates operational bottlenecks. A global scarcity of skilled healthcare practitioners further complicates matters, preventing the widespread application of these critical safety protocols in standard medical practice.

Market Driver

The market is being significantly propelled by breakthroughs in non-invasive and portable monitoring technologies, which allow for continuous fetal observation beyond the confines of traditional hospitals. These wireless devices monitor vital signs without keeping patients tethered to bedside machines, enhancing remote management capabilities and improving adherence to care plans. Such technological evolution permits the timely identification of complications in high-risk pregnancies without necessitating extended hospital stays, effectively balancing clinical safety with patient freedom. Illustrating this trend, GE HealthCare received FDA clearance in February 2024 for its Novii+ solution, expanding wireless monitoring options for a wider demographic. This rapid innovation is supported by strong financial backing; Silicon Valley Bank reported that venture capital investment in women's health hit $2.6 billion in 2024, providing crucial capital for developing these advanced diagnostic tools.

Furthermore, government support for maternal and infant health serves as a vital engine for growth by directing funds toward modernizing obstetric infrastructure. Public health bodies are prioritizing spending to lower mortality rates and close healthcare gaps, facilitating the purchase of medical-grade equipment in rural and underserved communities. These initiatives often subsidize the expense of sophisticated devices while enforcing strict safety standards to guarantee fair access to perinatal services. For instance, in October 2024, the Health Resources and Services Administration granted approximately $19 million to state-level projects designed to improve maternal health results and service availability. Such targeted public funding reduces economic obstacles for medical centers, encouraging the widespread adoption of necessary fetal assessment technologies.

Market Challenge

A major obstacle hindering the Global Fetal Monitoring Market is the necessity for specialized training alongside a worldwide lack of skilled healthcare workers. Fetal monitoring devices produce intricate physiological data, such as uterine contractions and fetal heart rate rhythms, which require high-level clinical knowledge for proper analysis. Failing to accurately differentiate between harmless variations and actual fetal distress can result in serious health consequences and substantial legal risks for healthcare providers. This reliance on expert interpretation generates a bottleneck, as the rollout of these diagnostic tools is limited by the availability of personnel capable of operating them and interpreting the results.

Consequently, the shortage of qualified midwives and obstetricians directly limits the ability to scale monitoring services, especially in areas with severe workforce shortages. Many medical institutions are compelled to restrict the implementation of advanced monitoring systems because they lack adequate staff to uphold rigorous surveillance protocols. According to the American College of Obstetricians and Gynecologists, the supply of obstetrician-gynecologists in the United States satisfied only 93.4% of the demand in 2025. This expanding disparity between clinical needs and workforce availability impedes the universal application of these vital safety measures, effectively stalling the market's growth.

Market Trends

The incorporation of Artificial Intelligence (AI) into predictive fetal analytics is transforming the market, shifting focus from basic data recording to real-time risk assessment. Modern algorithms are capable of examining complex heart rate patterns to detect distress signals sooner, thereby aiding clinical decisions regarding preterm and high-risk pregnancies. This evolution is highlighted by regulatory achievements that confirm AI's utility in broadening surveillance to include more vulnerable stages of gestation. For example, PeriGen obtained FDA clearance in February 2025 for its Patterns 3.0 software, extending its AI-driven pattern recognition to fetuses as young as 32 weeks. These innovations enable medical teams to handle critical cases with higher accuracy, diminishing the dependence on subjective analysis that frequently causes delays in acute care environments.

In parallel, the rise of smartphone-integrated smart monitoring tools is decentralizing prenatal services, empowering expectant mothers to conduct clinical-quality checks from home. These portable devices connect directly with mobile apps to send images and data to healthcare providers for remote evaluation, significantly lowering the frequency of required clinic visits. This shift toward consumer-oriented, connected healthcare was reinforced when Pulsenmore received FDA De Novo marketing authorization in November 2025 for its home-based prenatal ultrasound platform, which uses a smartphone dock to facilitate patient-guided scanning. This functionality effectively tackles the issue of care deserts by bridging the geographical gap between patients and obstetricians while ensuring a consistent flow of diagnostic-grade information.

Key Market Players

• Medtronic Plc
• Cardinal Health Inc.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• GE Healthcare Technologies Inc.
• FUJIFILM SonoSite, Inc
• Natus Medical Incorporated
• Huntleigh Healthcare Limited
• CooperCompanies Inc.
• CONTEC Medical Systems Co., Ltd

Report Scope

In this report, the Global Fetal Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fetal Monitoring Market, By Product

• Ultrasound
• Device
• Fetal Monitors
• Uterine Contraction Monitors
• Fetal Electrodes
• Fetal Doppler Device
• Telemetry Device
• Accessories and Consumables
• Others

Fetal Monitoring Market, By Portability

• Portable System and Non-Portable System

Fetal Monitoring Market, By Method

• Invasive and Non-invasive

Fetal Monitoring Market, By Application

• Antepartum
• Intrapartum

Fetal Monitoring Market, By End User

• Hospitals
• Obstetrics & Gynecology clinic
• Home Care Setting

Fetal Monitoring Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fetal Monitoring Market.

Available Customizations:

Global Fetal Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fetal Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Ultrasound, Device, Fetal Monitors, Uterine Contraction Monitors, Fetal Electrodes, Fetal Doppler Device, Telemetry Device, Accessories and Consumables, Others)
  • 5.2.2. By Portability (Portable System and Non-Portable System)
  • 5.2.3. By Method (Invasive and Non-invasive)
  • 5.2.4. By Application (Antepartum, Intrapartum)
  • 5.2.5. By End User (Hospitals, Obstetrics & Gynecology clinic, Home Care Setting)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Fetal Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Portability
  • 6.2.3. By Method
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fetal Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Portability
      • 6.3.1.2.3. By Method
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Fetal Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Portability
      • 6.3.2.2.3. By Method
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Fetal Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Portability
      • 6.3.3.2.3. By Method
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Fetal Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Portability
  • 7.2.3. By Method
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fetal Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Portability
      • 7.3.1.2.3. By Method
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Fetal Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Portability
      • 7.3.2.2.3. By Method
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Fetal Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Portability
      • 7.3.3.2.3. By Method
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Fetal Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Portability
      • 7.3.4.2.3. By Method
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Fetal Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Portability
      • 7.3.5.2.3. By Method
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Fetal Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Portability
  • 8.2.3. By Method
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Fetal Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Portability
      • 8.3.1.2.3. By Method
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Fetal Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Portability
      • 8.3.2.2.3. By Method
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Fetal Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Portability
      • 8.3.3.2.3. By Method
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Fetal Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Portability
      • 8.3.4.2.3. By Method
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Fetal Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Portability
      • 8.3.5.2.3. By Method
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Fetal Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Portability
  • 9.2.3. By Method
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Fetal Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Portability
      • 9.3.1.2.3. By Method
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Fetal Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Portability
      • 9.3.2.2.3. By Method
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Fetal Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Portability
      • 9.3.3.2.3. By Method
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Fetal Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Portability
  • 10.2.3. By Method
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Fetal Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Portability
      • 10.3.1.2.3. By Method
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Fetal Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Portability
      • 10.3.2.2.3. By Method
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Fetal Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Portability
      • 10.3.3.2.3. By Method
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Fetal Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cardinal Health Inc.
• 15.3. Koninklijke Philips N.V.
• 15.4. Siemens Healthineers AG
• 15.5. GE Healthcare Technologies Inc.
• 15.6. FUJIFILM SonoSite, Inc
• 15.7. Natus Medical Incorporated
• 15.8. Huntleigh Healthcare Limited
• 15.9. CooperCompanies Inc.
• 15.10. CONTEC Medical Systems Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer